Areas of Focus

• Mechanisms by which normal cells become cancerous with an emphasis on aberrant signal transduction pathways
• Receptor tyrosine kinases to transcription factors
• Oncogenesis at the basic science level, validating cancer-causing proteins and pathways, developing chemical probes to target such pathways, and ultimately performing biomarker-driven clinical trials
• Mechanism by which mutant KRas causes cancer